|1.||Yonese, Junji: 1 article (01/2013)|
|2.||Fukui, Iwao: 1 article (01/2013)|
|3.||Yuasa, Takeshi: 1 article (01/2013)|
|4.||Sakura, Mizuaki: 1 article (01/2013)|
|5.||Yamamoto, Shinya: 1 article (01/2013)|
|6.||Fujii, Yasuhisa: 1 article (01/2013)|
|7.||Tanaka, Hajime: 1 article (01/2013)|
|8.||Urakami, Shinji: 1 article (01/2013)|
|9.||Masuda, Hitoshi: 1 article (01/2013)|
|10.||Bae, H S: 1 article (12/2000)|
|1.||Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/01/1986 - "VIP combination chemotherapy demonstrates activity in this highly unfavorable population of patients with germ cell tumors. "
01/01/2013 - "This study re-evaluated the efficacy and tolerability of cisplatin, etoposide, and ifosfamide (VIP) combination chemotherapy as an alternative first-line regimen for patients with disseminated germ cell cancer (GCC) in this granulocyte colony-stimulating factor (G-CSF) era. "
|2.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/01/2000 - "VIP combination chemotherapy and early concurrent thoracic irradiation for patients with limited stage small cell lung cancer revealed excellent antitumor response with tolerable toxicity."
12/01/2000 - "We conducted a phase II study of etoposide (VP-16)-ifosfamide-cisplatin (VIP) combination chemotherapy plus early concurrent thoracic irradiation for the patients with previously untreated limited small cell lung cancer in order to assess if the treatment modality could improve the response rate and the toxicity. "
|1.||Etoposide (VP 16)
|4.||Granulocyte Colony-Stimulating Factor (G-CSF)
|5.||Vinblastine (Vinblastine Sulfate)
|1.||Drug Therapy (Chemotherapy)